Literature DB >> 23397143

Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases.

Chan Hee Lee1, Na Young Sung, Jisoo Lee, Sang-Cheol Bae.   

Abstract

The aim of this study was to identify the factors associated with gout among South Koreans. A case control study of gout patients newly diagnosed between January 1, 2007, and December 31, 2008, and matching controls was conducted using the nationwide database (National Health Insurance Corporation and National Health Screening Exam (NHSE) database), which included the health-care records of 48.1 million individuals. Of 495,998 newly diagnosed patients, we included 18,123 who were ≥40 years old and had an NHSE before diagnosis of gout. To elucidate the factors associated with gout, multivariate conditional logistic analyses were performed. Gout was associated with drinking ≥1/week (p < 0.001), drinking ≥1 bottle of soju/session (p < 0.001), high body mass index (BMI) (p < 0.001), high blood pressure (p < 0.001), high total cholesterol (p < 0.001), proteinuria (multivariate odds ratio (OR) = 1.75; 95 % confidence interval (CI) = 1.53-2.00), and an elevated uric acid (multivariate OR = 1.54; 95 % CI = 1.22-1.94). Exercise frequency was not significantly associated with gout. Prediabetic blood sugar level (100-125 mg/dL) was associated with gout in the univariate analysis, but not in the multivariate analysis. Diabetic blood sugar level (≥126 mg/dL) was associated with a decreased odds of gout (multivariate OR = 0.79; 95 % CI = 0.73-0.86). Our nationwide South Korean study showed that frequent and excessive alcohol consumption, high BMI, high blood pressure, high total cholesterol, proteinuria, and high uric acid are associated with gout.

Entities:  

Mesh:

Year:  2013        PMID: 23397143     DOI: 10.1007/s10067-013-2183-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  35 in total

1.  Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys.

Authors:  Soo Lim; Kyong Soo Park; Hong Kyu Lee; Sung-Il Cho
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

2.  Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.

Authors:  Angelo L Gaffo; Jeffrey M Roseman; David R Jacobs; Cora E Lewis; James M Shikany; Ted R Mikuls; Pauline E Jolly; Kenneth G Saag
Journal:  Ann Rheum Dis       Date:  2010-06-04       Impact factor: 19.103

3.  Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts.

Authors:  Mara A McAdams; Janet W Maynard; Alan N Baer; Anna Köttgen; Sandra Clipp; Josef Coresh; Allan C Gelber
Journal:  J Rheumatol       Date:  2010-12-01       Impact factor: 4.666

Review 4.  Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

Authors:  Ankoor Shah; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

5.  Prevalence and incidence of the diagnosis of gout in Great Britain.

Authors:  W J Currie
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

6.  Serum uric acid, serum glucose and diabetes: relationships in a population study.

Authors:  D G Cook; A G Shaper; D S Thelle; T P Whitehead
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

7.  Serum uric acid and incident diabetes in Mauritian Indian and Creole populations.

Authors:  Hairong Nan; Qing Qiao; Stefan Söderberg; Janne Pitkäniemi; Paul Zimmet; Jonathan Shaw; George Alberti; Ulla Uusitalo; Vassen Pauvaday; Pierrot Chitson; Jaakko Tuomilehto
Journal:  Diabetes Res Clin Pract       Date:  2008-03-04       Impact factor: 5.602

8.  Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis.

Authors:  Han-Gyul Yoo; Sang-Il Lee; Han-Jung Chae; Seoung Ju Park; Yong Chul Lee; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2009-12-20       Impact factor: 2.631

9.  Prevalence of the metabolic syndrome in individuals with hyperuricemia.

Authors:  Hyon K Choi; Earl S Ford
Journal:  Am J Med       Date:  2007-05       Impact factor: 4.965

10.  Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Authors:  L Annemans; E Spaepen; M Gaskin; M Bonnemaire; V Malier; T Gilbert; G Nuki
Journal:  Ann Rheum Dis       Date:  2007-11-02       Impact factor: 19.103

View more
  5 in total

1.  A meta-analysis of alcohol consumption and the risk of gout.

Authors:  Meiyun Wang; Xiubo Jiang; Wenlong Wu; Dongfeng Zhang
Journal:  Clin Rheumatol       Date:  2013-07-24       Impact factor: 2.980

2.  Seasonality of gout in Korea: a multicenter study.

Authors:  Hyo Jin Choi; Chan Hee Lee; Joo Hyun Lee; Bo Young Yoon; Hyoun Ah Kim; Chang Hee Suh; Sang Tae Choi; Jung Soo Song; HoYeon Joo; Sung Jae Choi; Ji Soo Lee; KiChul Shin; Jae-Bum Jun; Han Joo Baek
Journal:  J Korean Med Sci       Date:  2015-02-16       Impact factor: 2.153

3.  Trends in Diabetes Incidence in the Last Decade Based on Korean National Health Insurance Claims Data.

Authors:  Sun Ok Song; Yong Ho Lee; Dong Wook Kim; Young Duk Song; Joo Young Nam; Kyoung Hye Park; Dae Jung Kim; Seok Won Park; Hyun Chul Lee; Byung Wan Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06-10

4.  Systemic Investigation of Promoter-wide Methylome and Genome Variations in Gout.

Authors:  Chia-Chun Tseng; Man Chun Wong; Wei-Ting Liao; Chung-Jen Chen; Su-Chen Lee; Jeng-Hsien Yen; Shun-Jen Chang
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

5.  Metabolic syndrome: prevalence and risk factors in Korean gout patients.

Authors:  Jae Hyun Jung; Gwan Gyu Song; Jong Dae Ji; Young Ho Lee; Jae-Hoon Kim; Young Ho Seo; Sung Jae Choi
Journal:  Korean J Intern Med       Date:  2016-10-12       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.